Monash Antibody Technologies Facility (MATF) is one of the only high-throughput production facilities in the world generating novel custom-made, high-affinity monoclonal antibodies. It has been established to provide a global source of reagents for researchers in academia and industry, and to continuously advance proteomics-level technology developments.

The facility provides a range of monoclonal and polyclonal related services. Services include: Immunisation of mice, rats and rabbits to produce polyclonal antibodies. ELISA assays to determine antibody titre. Fusions of mouse/rat spleens for production of hybridomas. Cloning of hybridomas. Isotype testing of monoclonal antibodies. In vitro production of monoclonal [...]

The ISO9001 certified Recombinant Protein Production Facility (RPPF) provides Australian researchers with subsidised access to state-of-the-art facilities for large scale protein production, process development and optimisation using mammalian cell culture, fungal and microbial expression systems.